Upcoming Scientist Award

Poster presentations

Sponsor Poster Award

Interesting in sponsoring edition 2016, click here


To give young and upcoming scientists the possibility to spread their research and results amongst the key players and stakeholders across the life sciences & healthcare spectrum, poster sessions were organised at Innovation for Health.

Giulia de Luca won the Upcoming Scientist Award of 2015 and received €1.000,-. The award was handed out by Dr. Paul Parren, Sr. Vice President and Scientific Director of Genmab, also sponsor of the award.




The participating scientists were:

 
+ Annebet Leeuwis VUmc Alzheimer Center
+ Astrid Hooghiemstra VUmc Alzheimer Center
+ Giulia de Luca University of Amsterdam
+ Jelte Elsinga University of Groningen
+ Jochem Jansen Academic Medical Center Amsterdam
+ Judith Poldervaart Julius Center, UMCU
+ Lisa Law MRC Biostatistics Unit
+ Masum Mia University Medical Center Groningen

 
+ Nelleke Korteland Erasmus University Medical Center
+ Olympia Papchristofi MRC Biostatistics Unit
+ Randy Poelman University Medical Center Groningen
+ Rosalinde Slot VUmc Alzheimer Center
+ Ruoyu Xing Erasmus University Medical Center
+ Sahar Mokhles Erasmus University Medical Center
+ Sanne van der Weegen Maastricht University

 
+ Sonja Simpraga Center for Neurogenomics and Cognitive Research, VU

Study protocol: the effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment

Accumulating evidence suggests that physical activity benefits cognition in elderly. The beneficial effect of exercise on stroke prevention could suggest an increased perfusion of the brain as underlying mechanism. We aim to assess whether physical exercise increases cerebral blood flow (CBF) and to assess the effect on cognition, blood biomarkers, brain and cardiac structure and quality of life in patients with vascular cognitive impairment (VCI). In this randomized controlled trial a 14-week, thrice-weekly, aerobic exercise program is compared to a control group. Participants are 80 non-demented patients over 50 years, who are diagnosed with VCI. They undergo the same standardized set of imaging, neuropsychological and physical assessments. The primary outcome measure is CBF, measured by Arterial Spin Labeling (ASL)-MRI. The first results are expected in early 2017. This intervention study is funded by “CardioVasculair Onderzoek Nederland” (CVON) and is performed on behalf of the Heart-Brain-Axis study group.

VUmc Alzheimer Center, Annebet Leeuwis

The Heart-Brain Connection study protocol: The missing link in the pathophysiology of vascular cognitive impairment

On behalf of the Heart-Brain study group: Heart disease is increasingly recognized as a contributor to memory problems and dementia. We aim to assess the association between heart and blood flow abnormalities and cognitive functioning (e.g. memory functioning), possibly mediated through altered brain structure and blood flow. In this study 600 patients aged over 50 years, diagnosed with either vascular cognitive impairment, blockage of the carotid artery, or with heart failure, as well as 120 healthy controls undergo the same standardized set of tests: blood testing, blood pressure, ECG, memory testing, and assessment of daily functioning and depression. Furthermore, heart and brain MRI is performed. Follow-up is after one and two years. The first results are expected in early 2019. This multicenter study is funded by “CardioVasculair Onderzoek Nederland” (CVON), and is a collaboration of AMC Amsterdam, Erasmus MC, LUMC, Maastricht UMC, UMC Utrecht, and VUmc.

VUmc Alzheimer Center, Astrid Hooghiemstra


Re-scan Confocal Microscopy

Microscopes are built to make sharp images of an object with a strong magnification. For biomedical research, high magnification microscopes allow observation of the smallest details in cells with the highest resolution. However, there is a fundamental limit to resolution and, consequently, to magnification. This phenomenon is described by Abbe’s Law which tells that it is not possible to see details smaller than half the wavelength of light (~250 nm).
We have invented a new super-resolution technique to obtain 40% better resolution than Abbe’s limit. Our method is simple to use, robust and relatively inexpensive. This new super-resolution technique, “Re-scan Confocal Microscopy” (RCM), is based on standard microscopy extended with two optical scanners forming the heart of the microscope. One scanner “reads the sample” by directing laser light to the sample. The other scanner, the re-scanner, “writes the image” on a camera. The trick to obtain super resolution is that we apply an additional step of magnification by increasing the amplitude of the second scanner by a factor of two. With this method, we measure details down to 170 nm, which is a 40% resolution improvement compared to Abbe’s limit (250 nm).

Dutch Technology Foundation STW, Giulia de Luca

Health seeking behaviour and treatment intentions of dengue and fever: a hh survey of children and adults in Venezuela

Dengue is a viral disease spread by mosquitoes, affecting approximately 400 million persons annually. Early diagnosis and treatment influences the outcome of dengue illness. We aimed to understand intended patterns of health seeking behaviour (HSB) in individuals exposed to high dengue incidence in order to improve early attendance to health centres. We performed a cross-sectional household survey in Maracay, Venezuela. Intended HSB of adults and parents/guardians was assessed in 105 individuals using structured questionnaires. Intended pathways to care differed for suspected dengue compared to fever, and between children and adults. Moreover, a suspected dengue infection would prompt people to search medical help earlier than for fever. Considering that people would show more adequate HSB when they knew they had dengue but the identification of a dengue infection still is challenging, we conclude that improving knowledge and awareness of dengue symptoms may enhance early attendance to medical care.

University of Groningen, Jelte Elsinga

Alcohol dependence and the relation to impaired processing and handling of negative emotions

The ability to manage emotional information is central to our daily functioning and often impaired addicted patients. The consumption of alcohol reduces negative emotion and enhances positive emotion; in other words, alcohol is an emotion regulator. Relying heavily on this mechanism of ‘self-medication’ is related to more alcohol related problems. Therefore it is relevant to improve the handling of emotional information, or emotion regulation. Differences in performance and brain activity between alcohol dependent patients and healthy controls have never been tested with an emotion regulation task. Therefore, an emotion regulation task is administered within a group of alcohol dependent patients and healthy controls inside an fMRI scanner and participants receive one session of a new non-invasive neurostimulation technique (called rTMS) in order to improve emotion regulation and assess the effect this technique has on brain function. The results indicate that rTMS improves performance on the emotion regulation task and changes brain functioning in alcohol dependent patients. 

Academic Medical Center Amsterdam, Jochem Jansen

Evaluating the impact of the HEART risk score in chest pain patients using a stepped wedge design

Chest pain remains a diagnostic challenge: it can be a symptom of a heart attack. Therefore, most chest pain patients are admitted to the hospital for further testing. However, most of these patients do not have anything severe and could have been sent home safely without further testing. How can we identify these patients? The HEART risk score provides the doctor with a simple, quick and reliable predictor of cardiac risk. We studied how the use of this HEART score in daily practice impacts patient outcomes, quality of life and costs. Last year we included 3,666 patients with chest pain presenting at the Emergency Department in 9 Dutch hospitals. All hospitals started with a period of ‘normal care’ and during the study switched to ‘HEART score care’: calculation of the HEART score in each patient to guide doctors’ decision; reassurance and discharge of patients with low scores and intensive monitoring/intervention in patients with high scores. 

Julius Center, UMCU, Judith Poldervaart


An Adaptive trial design for better evaluation of the benefits of telehealth

One of the biggest barriers to widespread implementation of telehealth technology in healthcare systems is the lack of strong evidence of its benefits.  This lack of evidence is often due to flaws in trial design.  The aim of my work is to investigate alternative options of trial design, to allow more accurate and efficient evaluation of telehealth.  My project is partly funded by Philips Research Cambridge, who has a growing number of telehealth projects.   One example is their personal healthcare system for monitoring the symptoms of chronically ill patients at home.  This includes an alert system which automatically notifies the healthcare team if a patient’s symptom exceeds a specified cut-off.  Recognising the importance of this cut-off, I propose a new design which aims to adjust the cut-off to an optimal value during the trial, allowing the monitoring system to be both optimised and evaluated within a single trial.

MRC Biostatistics Unit, Lisa Law

Fetal stem cells show high anti-scarring properties

Fibrosis (Scarring) is a defective tissue repair process often seen after long-lasting injury in many organs, such as the lung, kidney and the skin. So far, no drugs have been developed that can be used to reduce or prevent fibrosis. In this study, we treated the adult skin myofibroblasts (are key cells involed in fibrosis) with the fetal and adult origin of stem cells. We found that the secreted products of fetal stem cells create more powerful anti-fibrotic environment than adult stem cells. From these observations, it appears that fetal stem cells have potential wound healing properties for adult skin, and most likely also for other organs that are prone to scarring.

University Medical Center Groningen, Masum Mia

Shared decision-making in prosthetic heart valve selection

For heart valve replacement, two options exist: a mechanical and bioprosthetic valve. Survival in adult patients is comparable with these two types of valves. Therefore the choice for a valve prosthesis is driven by valve-related event occurrence. The nature of these events is completely different for these two types of valves and the decision is therefore highly preference sensitive. There is broad support for shared decision-making (SDM) among cardiovascular professionals and heart valve patients. Unfortunately, there are no tools available to support SDM. Therefore, we started a project to develop and test a patient decision aid for prosthetic heart valve selection. Currently we are testing the decision aid in a multicenter RCT and after that we will introduce it in cardiovascular practice. We expect this to result in better informed and more actively involved patients, and a higher quality of decision-making in the setting of prosthetic heart valve selection. 

Erasmus Medical Center, Nelleke Korteland

Enhancement of an IDEAL framework for the assessment of surgical interventions: understanding the complexities and constructing the solutions

My project deals with the assessment of the impact of learning curves and multiple operators in clinical trials of surgical and complex interventions. Firstly, it is expected surgeon performance for novel operations will improve with increasing experience; this learning effect may complicate the evaluation of the intervention by either delaying the start of the trial, or by masking its true impact if surgical performance has not stabilised before evaluation.  We constructed a model estimating the learning rate, the learning period duration and the final skill level achieved, in order to adjust for learning effects during assessment. Secondly, complications during assessment caused by the multidisciplinary nature of surgery are of interest. The extent to which patients treated by the same medical team are more likely to have the same outcome is investigated using a series of hierarchical models considering surgeon principal effects or,  the effects of the next most influential team member, the anaesthetist, as well as adjustment for patient heterogeneity. 

MRC Biostatistics Unit, Olympia Papchristofi

REGIOTYPE, an adequate regional viral surveillance strategy

MIn our tertiary referral hospital, we routinely screen patients suspected for viral infections. A number of viruses are subsequently typed in order to identify viral strains and to chart outbreaks and transmission patterns. Additionally, we implemented a rapid regional sequencing service called REGIOTYPE, by including primary and secondary healthcare institutions covering the Northern part of the Netherlands. This allows us to complete our diagnostics with epidemiological data and as clinical data are included, to collect information which provides insights into the circulation of viral strains and their relatedness within multiple institutions. This fast sequencing strategy even provides a predictive value in the local circulation of different types of viruses and enables the early application of infection control measures for the participating healthcare institutions, including those in our own hospital. 

University Medical Center Groningen, Randy Poelman


Subjective Cognitive Impairment Cohort (SCIENCe)- focus on the earliest changes leading to Alzheimer's disease

The primary goal of the SCIENCe study is to investigate the first signs of Alzheimer’s Disease and factors contributing to cognitive decline. Dementia is a worldwide growing epidemic, with increasing longevity as important risk factor. The most common cause of dementia is Alzheimer’s Disease. Already 25 years prior to the diagnosis of Alzheimer’s Disease, the first Alzheimer changes in the brain are seen. Memory complaints can be the first sign of Alzheimer’s Disease, but the majority of patients with memory complaints do not develop Alzheimer’s. The SCIENCe study investigates patients with memory complaints, without clear cognitive impairment. Patients are followed for at least five years. Patients receive extensive neuropsychological assessment, as well as questionnaires on lifestyle and psychic health, MRI and PET scanning. Also, blood, DNA and cerebrospinal fluid are analyzed. The major outcome is cognitive decline. Identifying Alzheimer’s Disease in its earliest stage will have important consequences for future treatment of this devastating disease.

VUmc Alzheimer Center, Rosalinde Slot



Increased risk of stroke or heart attack: is blood flow the cause?

Atherosclerosis is the build-up of fatty materials called plaques inside the artery wall. If a plaque ruptures it can cause stroke or heart attack. Previous research suggested that the frictional force exerted by flowing blood on the cells lining the artery can influence plaque composition, thus increasing its risk of rupture. My project investigates the link between blood flow and the development of rupture-prone plaques. By surgically manipulating flow through the artery of a mouse, I created a stable and a rupture-prone plaque in the mouse artery. I imaged these mice several times during plaque development and then constructed computer models of blood flow. Next, I will analyze plaque composition using staining techniques. Ultimately, I want to find the link between blood flow and rupture-prone plaques. This will provide a better understanding of the disease process causing stroke or heart attacks and will help the search for novel treatments.

Erasmus Medical Center, Ruoyu Xing



Optimal Clinical Decision Making in Patients with Non-Small Cell Lung Cancer

Lung cancer remains the most common cause of cancer-specific mortality worldwide. In these group of patients guidelines strongly guide decision-making. However, it is important to involve patients in decision-making to improve quality of life, and to avoid unnecessary medical interventions and costs. The purpose of this study is to investigate the role of the patient with early stage non-small-cell-lung-cancer in decision-making process concerning treatment selection. This study illustrate that 46% of patients experienced personal uncertainty (decisional-conflict). Personal uncertainty is prevalent when patients are uninformed and uncertain about treatment options. Furthermore, improvement of information conveyance, and involvement of patients in treatment decision-making is needed. Involvement of patients will help them to understand their prognosis and to make informed treatment decisions. This is important for quality of life of these patients since there is lack of consensus about the optimal treatment. Better strategies, such as information portals and decision aids, are needed.

Erasmus Medical Center, Sahar Mokhles

It’s LiFe! project

In the It’s LiFe! project a monitoring and feedback tool was developed, which measures physical activity with an activity monitor and gives personalized feedback on a smartphone app and a website, to support users in their self-management to become more active. Besides the direct feedback in relation to a personal goal, behavior change dialogue sessions are sent and the practice nurse in the general practice automatically receives the results and uses these results in the behavior change consultations. A Self-management Support Program (SSP) was developed to guide the practice nurse in this coaching role.
Patients and care givers were intensively involved in the iterative user-centered development process of the tool and the SSP. After this the usability of the tool, the validity of the activity monitor and the feasibility of the combined intervention was tested. Currently we are investigating the effects of the tool embedded in the SSP, by a Randomized Controlled Trial in 24 general practices.

Maastricht University (Caphri), Sanne van der Weegen

 
Is EEG biomarker integration the key to personalized medicine? 

Brain disorders are a major health care burden, mostly due to inaccurate diagnosis and insufficient treatment options. Hence the urgent need for biomarkers, as the current ones are not sensitive and specific enough, because individual biomarkers overlap between healthy subjects and patients. This is why we propose an integrative EEG biomarker approach as multiple biomarkers provide complementary neurological information and better capture the unique phenotype of an individual (patient). Recently, we showed that EEG biomarker integration significantly improves the prediction of conversion from mild cognitive impairment to Alzheimer’s disease compared with a single biomarker based prediction. Here we provide additional proof of concept on a twin dataset, yielding a set of heritable biomarkers which can be used as an index, for diagnosis, prognosis or monitoring. The high heritability of EEG biomarkers also implies a high test-retest reliability, which is crucial in clinical measurements, for longitudinal monitoring of treatment effects.

VU University Amsterdam, Sonja Simpraga

All the entries for 2014 can be found here.
For any questions, please contact Kimberley Vera via k.vera@hyphenprojects.nl or +31(0)35 303 0343.

 Awards  Program  Exhibitors list

Recommended by:


Rob van Leen, DSM

Speakers, a.o.:


Angelique Berg, Ministry of Health, Welfare and Sports

Register for the newsletter

Sign up for the newsletter to stay updated about Innovation for Health.
It also possible to folluw us on social media.

Save the date

Mark your agenda, Innovation for Health 2016 will take place the 18th of February in Beurs-WTC Rotterdam. Click here for a preview! 

Twitterfeed